Stress associated with worse recovery in women after myocardial infarction
the ONA take:
Current study findings suggest that the higher level of living stress young and middle-age women when compared to their male counterparts could negatively impact them when recovering from acute myocardial infarction (AMI).
In general, surveyed women report a higher level of stress than men, possibly owing to differing gender roles in both work and family-related situations. Yale School of Medicine researchers examined data from the Variation in Recovery: Role of Gender Outcomes on Young AMI Patients (VIRGO) study, focusing on women of ages 18 through 55 who experienced an AMI event.
Results of a questionnaire about self-perceived stress were compared with each patient's recovery, in an attempt to explore the daily stressors in the patients' lives.
First author Xiao Xu, an assistant professor in the Department of Obstetrics, Gynecology & Reproductive Sciences at Yale School of Medicine, feels that this stress level could well be a reason for the different average rates of AMI recovery for men and women. Rates of diabetes, stroke, congestive heart failure, and lung disease are also higher in women, compared to men.
higher level of living stress young and middle-age women could negatively impact them when recovering from AMI.
Sign Up for Free e-newsletters
- Triplet Regimen Found Most Effective for Relapsed/Refractory Multiple Myeloma
- Integrating Preoperative Oral Care Into Cancer Treatment Plans
- Current Status and Dilemma of Second-line Treatment in Advanced Pancreatic Cancer: Is There a Silver Lining?
- American Association for Cancer Research Releases Its 2018 Annual Report
- Pulmonary Toxicity Increased in Pediatric Hodgkin Lymphoma Treated With Brentuximab Vedotin
- Benefit of Chemotherapy for Breast Cancer Observed With Midrange Gene Assay Score
- Antioxidant Interaction With Cancer Therapy
- Young Survivors of Breast Cancer Report Sexual Quality of Life Declines After Treatment
- Myeloablative Conditioning Effective in AML Secondary to MDS/MPN Prior to Allogeneic HCT
- Insurance Status Influences Overall Survival in Follicular Lymphoma
- Skin Cancer Screening: Are They Effective?
- Metronidazole, Vancomycin Recommended for C Difficile in Pediatric Oncology, HSCT
- CDC: HPV Vaccination Rates on the Rise Among Adolescents
- High-Dose vs Standard-Dose Flu Vaccine in Elderly Receiving Chemotherapy
- FDA Grants Approval to Novel Treatment for Hairy Cell Leukemia
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|